Recurrent miscarriage

Journal of Family Planning and Reproductive Health Care

Volumn 31, Issue 2, 2005, Pages 103-107

  Horne, Andrew W ^a   Alexander, Claire I ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT;

ADOPTION; ANTIPHOSPHOLIPID SYNDROME; CHROMOSOME ABERRATION; ENDOMETRIAL DISEASE; FIRST TRIMESTER PREGNANCY; HUMAN; IDIOPATHIC DISEASE; IMMUNOPATHOLOGY; KARYOTYPE; METABOLIC DISORDER; PRENATAL DIAGNOSIS; RECURRENT ABORTION; REVIEW; SOCIAL SUPPORT; SPONTANEOUS ABORTION; THROMBOPHILIA; UTERINE CERVIX DISEASE; UTERUS MALFORMATION;

ABORTION, HABITUAL; ANTIPHOSPHOLIPID SYNDROME; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; KARYOTYPING; LIFE STYLE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; THROMBOPHILIA; UTERINE CERVICAL INCOMPETENCE; UTERUS;

EID: 18044392941     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/1471189053629428     Document Type: Review

References (94)

1. Stirrat GM. Recurrent miscarriage. Lancet 1990; 336: 673-675.
2. Alberman E. The epidemiology of repeated abortion. In: Beard RW, Sharp F (eds), Early Pregnancy Loss: Mechanisms and Treatment. London, UK: RCOG Press, 1988; 9-17.
3. Abdalla HI, Burton G, Kirkland A, Johnson MR, Leonard T, Brooks AA, et al. Age, pregnancy and miscarriage: uterine versus ovarian factors. Hum Reprod 1993; 8: 1512-1517.
4. Munne S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril 1995; 64: 382-391.
5. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320: 1708-1712.
6. Poland BJ, Miller JR, Jones DC, Trimble BK. Reproductive counseling in patients who have had a spontaneous abortion. Am J Obstet Gynecol 1977; 127: 685-691.
7. Regan L, Braude PR, Trembath PL. Influence of past reproductive performance on risk of spontaneous abortion. BMJ 1989; 299: 541-545.
8. Stenchever MA, Droegemueller W, Herbst AL, Mishell DR (eds). Spontaneous and recurrent abortion. In: Comprehensive Gynecology (4th edn). St Louis, MO: CV Mosby, 2001; 280-299.
9. De Braekeleer M, Dao TN. Cytogenetic studies in couples experiencing repeated pregnancy losses. Hum Reprod 1990; 5: 519-528.
10. Clifford K, Rar R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod. 1994; 9: 1328-1332.
11. Quenby S, Bates M, Doig T, Brewster J, Lewis-Jones DI, Johnson PM, et al. Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod 1999; 14: 2386-2391.
12. Simon C, Rubio C, Vidal F, Gimenez C, Moreno C, Parrilla JJ, et al. Increased chromosome abnormalities in human preimplantation embryos after in-vitro fertilization in patients with recurrent miscarriage. Reprod Fertil Dev 1998; 10: 87-92.
13. Vidal F, Gimenez C, Rubio C, Simon C, Pellicer A, Santalo J, et al. FISH preimplantation diagnosis of chromosome aneuploidy in recurrent pregnancy wastage. J Assist Reprod Genet 1998; 15: 310-313.
14. Pellicer A, Rubio C, Vidal F, Minguez Y, Gimenez C, Egozcue J, et al. In vitro fertilization plus preimplantation genetic diagnosis in patients with recurrent miscarriage: an analysis of chromosome abnormalities in human preimplantation embryos. Fertil Steril 1999; 71: 1033-1039.
15. Gianaroli L, Magli MC, Ferraretti AP. The in vivo and in vitro efficiency and efficacy of PGD for aneuploidy. Mol Cell Endocrinol 2001; 183(Suppl. 1): 13-18.
16. Munne S, Magli C, Cohen J, Morton P, Sadowy S, Gianaroli L, et al. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum Reprod 1999; 14: 2191-2199.
17. Cobo A, Rubio C, Gerli S, Ruiz A, Pellicer A, Remohi J. Use of fluorescence in situ hybridization to assess the chromosomal status of embryos obtained from cryopreserved oocytes. Fertil Steril 2001; 75: 354-360.
18. Robinson WP, Beever C, Brown CJ, Stephenson MD. Skewed X inactivation and recurrent spontaneous abortion. Semin Reprod Med 2001; 19: 175-181.
19. Giorlandino C, Calugi G, Iaconianni L, Santoro ML, Lippa A. Spermatozoa with chromosomal abnormalities may result in a higher rate of recurrent abortion. Fertil Steril 1998; 3: 576-577.
20. Rubio C, Simon C, Blanco J, Vidal F, Minguez Y, Egozcue J, et al. Implications of sperm chromosome abnormalities in recurrent miscarriage. J Assist Reprod Genet 1999; 16: 253-258.
21. Egozcue S, Blanco J, Vendrell JM, Garcia F, Veiga A, Aran B, et al. Human male infertility: chromosome anomalies, meiotic disorders, abnormal spermatozoa and recurrent abortion. Hum Reprod Update 2000; 6: 93-105.
22. Rai RS, Regan L, Clifford K, Pickering W, Dave M, Mackie I, et al. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 1995; 10: 2001-2005.
23. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166: 1318-1323.
24. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisolone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993; 169: 1411-1417.
25. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) BMJ 1997; 314: 253-257.
26. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002; 100: 408-413.
27. Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002; 99: 135-144.
28. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997; 77: 822-824.
29. Younis JS, Brenner B, Ohel G, Tal J, Lanir N, Ben-Ami M. Activated protein C resistance and factor V Leiden mutation can be associated with first- as well as second-trimester recurrent pregnancy loss. Am J Reprod Immunol 2000; 43: 31-35.
30. Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K, et al. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 2001; 5: 961-965.
31. Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 2000; 83: 693-697.
32. Ogueh O, Chen MF, Spurll G, Benjamin A. Outcome of pregnancy in women with hereditary thrombophilia. Int J Gynaecol Obstet 2001; 74: 247-253.
33. Rai R. Is miscarriage a coagulopathy? Curr Opin Obstet Gynecol 2003; 15: 265-268.
34. Rai R, Tuddenham E, Backos M, Jivraj S, El'Gaddal S, Choy S, et al. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum Reprod 2003; 18: 2540-2543.
35. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990; 336: 1141-1144.
36. Clifford K, Rai R, Watson H, Franks S, Regan L. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. BMJ 1996; 312: 1508-1511.
37. Hughes E, Collins J, Vandekerckhove P. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome. Cochrane Database Syst Rev 2000; 2: CD000087.
38. Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and recurrent miscarriage - a reappraisal. Hum Reprod 2000; 15: 612-615.
39. Li TC, Spuijbroek MD, Tuckerman E, Anstie B, Loxley M, Laird S. Endocrinological and endometrial factors in recurrent miscarriage. Br J Obstet Gynaecol 2000; 107: 1471-1479.
40. Nardo LG, Rai R, Backos M, El-Gaddal S, Regan L. High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril 2002; 77: 348-352.
41. Okon MA, Laird SM, Tuckerman EM, Li TC. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril 1998; 69: 682-690.
42. Bussen S, Sutterlin M, Steck T. Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Hum Reprod 1999; 14: 18-20.
43. Watson H, Franks S, Bonney RC. Regulation of epidermal growth factor receptor by androgens in human endometrial cells in culture. Hum Reprod 1998; 13: 2585-2591.
44. Tuckerman EM, Okon MA, Li T, Laird SM. Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril 2000; 74: 771-779.
45. Dlugi AM. Hyperprolactinemic recurrent spontaneous pregnancy loss: a true clinical entity or a spurious finding? Fertil Steril 1998; 70: 253-255.
46. Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res 2002; 10: 551-554.
47. Craig LB, Ke RW, Kutteh WH. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril 2002; 78: 487-490.
48. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 524-529.
49. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002; 17: 2858-2864.
50. Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van Allen M, Aarons JH, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988; 319: 1617-1623.
51. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002; 12: 63-68.
52. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994; 308: 295-298.
53. Ralph SG, Rutherford AJ, Wilson JD. Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ 1999; 319: 220-223.
54. Summers PR. Microbiology relevant to recurrent miscarriage. Clin Obstet Gynecol 1994; 37: 722-729.
55. Regan L, Jivraj S. Infection and pregnancy loss. In: Maclean A, Regan L, Carrington D (eds), Infection and Pregnancy. London, UK: RCOG Press, 2001; 291-304.
56. Homer HA, Li TC, Cooke ID. The septate uterus: a review of management and reproductive outcome. Fertil Steril 2000; 73: 1-14.
57. Fedele L, Bianchi S, Marchini M, Franchi D, Tozzi L, Dorta M. Ultrastructural aspects of endometrium in infertile women with septate uterus. Fertil Steril 1996; 65: 750-752.
58. Asherman JG. Traumatic intra-uterine adhesions. J Obstet Gynaecol Br Emp 1950; 57: 892-896.
59. Valle RF, Sciarra JJ. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol 1988; 158: 1459-1470.
60. Li TC, Mortimer R, Cooke ID. Myomectomy: a retrospective study to examine reproductive performance before and after surgery. Hum Reprod 1999; 14: 1735-1740.
61. Bajekal N, Li TC. Fibroids, infertility and pregnancy wastage. Hum Reprod Update 2000; 6: 614-620.
62. Tulppala M, Bjorses UM, Stenman UH, Wahlstrom T, Ylikorkala O. Luteal phase defect in habitual abortion: progesterone in saliva. Fertil Steril 1991; 56: 41-44.
63. Li TC. Guides for practitioners. Recurrent miscarriage: principles of management. Hum Reprod 1998; 13: 478-482.
64. Karamardian LM, Grimes DA. Luteal phase deficiency: effect of treatment on pregnancy rates. Am J Obstet Gynecol 1992; 167: 1391-1398.
65. Dalton CF, Laird SM, Estdale SE, Saravelos HG, Li TC. Endometrial protein PP14 and CA-125 in recurrent miscarriage patients; correlation with pregnancy outcome. Hum Reprod 1998; 13: 3197-3202.
66. Dalton CF, Laird SM, Serle E, Saravelos H, Warren MA, Li TC, et al. The measurement of CA 125 and placental protein 14 in uterine flushings in women with recurrent miscarriage; relation to endometrial morphology. Hum Reprod 1995; 10: 2680-2684.
67. Horne AW, White JO, Lalani el-N. Adhesion molecules and the normal endometrium. Br J Obstet Gynaecol 2002; 109: 610-617.
68. Horne AW, White JO, Lalani EN. The endometrium and embryo implantation. A receptive endometrium depends on more than hormonal influences. BMJ 2000; 321: 1301-1302.
69. Aplin JD, Hey NA, Li TC. MUC1 as a cell surface and secretory component of endometrial epithelium: reduced levels in recurrent miscarriage. Am J Reprod Immunol 1996; 35: 261-266.
70. Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2000; 2: CD000112.
71. Lin QD. Investigation of the association between autoantibodies and recurrent abortions. Zhonghua Fu Chan Ke Za Zhi 1993; 28: 674-677, 702.
72. Tulppala M, Palosuo T, Ramsay T, Miettinen A, Salonen R, Ylikorkala O. A prospective study of 63 couples with a history of recurrent spontaneous abortion: contributing factors and outcome of subsequent pregnancies. Hum Reprod 1993; 8: 764-770.
73. Pratt DE, Kaberlein G, Dudkiewicz A, Karande V, Gleicher N. The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester abortions in the next pregnancy. Fertil Steril 1993; 60: 1001-1005.
74. Bussen S, Steck T. Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions. Hum Reprod 1995; 10: 2938-2940.
75. Rushworth FH, Backos M, Rai R, Chilcott IT, Baxter N, Regan L. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod 2000; 15: 1637-1639.
76. Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, Chung-Bang H, Ng SC, Beaman KD, et al. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001; 16: 855-861.
77. Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten I. Peripheral natural killer cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 2000; 15: 1163-1169.
78. Makhseed M, Raghupathy R, Azizieh F, Omu A, Al-Shamali E, Ashkanani L. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001; 16: 2219-2226.
79. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359: 76-79.
80. Lim KJ, Odukoya OA, Ajjan RA, Li TC, Weetman AP, Cooke ID. The role of T-helper cytokines in human reproduction. Fertil Steril 2000; 73: 136-142.
81. von Wolff M, Thaler CJ, Strowitzki T, Broome J, Stolz W, Tabibzadeh S. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod 2000; 6: 627-634.
82. Lachapelle MH, Miron P, Hemmings R, Roy DC. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996; 156: 4027-4034.
83. Clifford K, Flanagan AM, Regan L. Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 1999; 14: 2727-2730.
84. Anthony GS, Walker RG, Cameron AD, Price JL, Walker JJ, Calder AA. Transabdominal cervico-isthmic cerclage in the management of cervical incompetence. Eur J Obstet Gynecol Reprod Biol 1997; 72: 127-130.
85. Althuisius SM, Dekker GA, Hummel P, Bekedam DJ, van Geijn HP. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2001; 185: 1106-1112.
86. MRC/RCOG Working Party on Cervical Cerclage. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologist multicentre randomised trial of cervical cerclage. Br J Obstet Gynaecol 1993; 100: 516-523.
87. Dominguez-Rojas V, de Juanes-Pardo JR, Astasio-Arbiza P, Ortega-Molina P, Gordillo-Florencio E. Spontaneous abortion in a hospital population: are tobacco and coffee intake risk factors? Eur J Epidemiol 1994; 10: 665-658.
88. Florey CD. EUROMAC. A European concerted action: maternal alcohol consumption and its relation to the outcome of pregnancy and child development at 18 months. Int J Epidemiol 1992; 21(Suppl. 1): 38-39.
89. Parazzini F, Chatenoud L, Di Cintio E, Mezzopane R, Surace M, Zanconato G, et al. Coffee consumption and risk of hospitalized miscarriage before 12 weeks of gestation. Hum Reprod 1998; 13: 2286-2291.
90. Rasch V. Cigarette, alcohol, and caffeine consumption: risk factors for spontaneous abortion. Acta Obstet Gynecol Scand 2003; 82: 182-188.
91. Katz VL, Kuller JA. Recurrent miscarriage. Am J Perinatal 1994; 11: 386-397.
92. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984; 148: 140-146.
93. Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 1997; 12: 387-389.
94. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999; 14: 2868-2871.